Raleigh company launches virtual, mobile clinical platform

A global contract research organization with headquarters in Raleigh has developed what it describes as the “first-ever completely virtual” clinical trial for drug indication. In fact, PRA Health Sciences announced that Janssen Pharmaceutical Companies of Johnson & Johnson is using the mobile clinical platform to launch a clinical trial assessing the effectiveness of of INVOKANA® (canagliflozin) in adults with heart failure with or without type 2 diabetes. Click here to learn more.

 

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.